Top Analyst Upgrades and Downgrades: Axovant, Carnival, Micron, Nike, SunPower, Vivint Solar, Walgreens and More

Print Email

Stocks have sold off in recent days, with a four-day losing streak for the Dow Jones Industrial Averages. Wednesday was showing some strength after the president’s tax plan is being shown on Wednesday. It is important to keep in mind that the Dow is still only about 100 points under last week’s all-time high. The trend that has dominated this eight-year bull market is that investors keep finding various new reasons to buy stocks after every market sell-off. Those same investors also are looking for new investing and trading ideas to generate gains and income.

24/7 Wall St. reviews dozens of analyst research reports each day of the week to find new investing and trading ideas for our readers. Some of the top analyst reports cover stocks to buy. Other calls cover stocks to sell or to avoid.

Additional color and commentary has been added on some of these daily analyst calls. The consensus analyst price target data are from the Thomson Reuters sell-side research service.

These were the top analyst upgrades, downgrades and other research calls from Wednesday, September 27, 2017.

Axovant Sciences Ltd. (NASDAQ: AXON) was destroyed on Tuesday with a 74% drop to $6.33 after its Alzheimer’s disease study failed. Jefferies still has a Buy rating, but the price target was slashed to $12 from $40, so that rating seems odd. Its shares were indicated up 5% at $6.65 on Wednesday, and its new 52-week trading range is $6.13 to $27.98.

Carnival Corp. (NYSE: CCL) was maintained as Buy at Argus with a $78 price target. Credit Suisse maintained a Neutral rating and trimmed estimates. Wedbush Securities maintained its Neutral rating and $67 target. Carnival shares were up 2.9% at $65.32 on Tuesday, in a 52-week range of $45.92 to $69.89.

Micron Technology Inc. (NASDAQ: MU) was down 2% at $34.18 ahead of earnings, but its shares were last seen up 5% at $35.90 after it beat earnings and signaled strong demand ahead. Credit Suisse reiterated its Outperform rating and raised its target to $50 from $40. Loop Capital reiterated its Buy rating and raised its target to $48 from $46. Deutsche Bank raised its target to $43 from $42, Morgan Stanley raised its target to $39 from $36 and Susquehanna raised its target to $54 from $50. The 52-week range is $16.17 to $36.60, and the consensus analyst price target is $44.69.

Nike Inc. (NYSE: NKE) closed at $53.70 ahead of earnings and its shares were indicated down 2.8% at $52.20 on Wednesday, with some of the earnings beat based on cost cutting and on low expectations. Jefferies maintained a Hold rating and lowered its target to $48 from $49 due to market share loss and wholesale exposure acting as drags. Wedbush maintained its Neutral rating and $52 price target. Canaccord Genuity lowered its target to $50 from $51, and Cowen cut its target to $50 from $53. Nike has a 52-week range of $49.01 to $60.53 and a consensus price target of $60.40.

SunPower Corp. (NASDAQ: SPWR) was downgraded to Underweight from Equal Weight with a $6 price target (versus a $7.22 prior close) at Morgan Stanley. The 52-week range is $5.84 to $11.70, and the consensus price target is $9.31.

Vivint Solar Inc. (NYSE: VSLR) was started with a Buy rating and assigned a $5 price target (versus a $3.25 close) at Guggenheim. Vivint Solar has a 52-week range of $2.50 to $6.09 and a consensus price target of $5.25.

Walgreens Boots Alliance Inc. (NASDAQ: WBA) was downgraded to Market Perform from Outperform at Raymond James. After closing at $79.08, Walgreens has a 52-week range of $75.18 to $89.69 and a consensus analyst target of $93.09.

24/7 Wall St. has identified 15 stocks with 10% dividend yields that may even have upside too.

Follow @Jonogg on Twitter to receive the daily analyst calls and other market research calls directly on your feed.

Other key analyst upgrades and downgrades were seen in the following: